Recent studies have demonstrated that Nrf2 levels are significantly higher in GBM cell lines, demonstrating that Nrf2 expression and IDH mutations are implicated in the molecular pathogenesis of gliomas [11]. This evidence concerns the gene IDH1 and glioma.